1. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
   Sabine Hombach-Klonisch et al, 2018, Pharmacology & Therapeutics CrossRef
2. WNT signaling modulates chemoresistance to temozolomide in p53-mutant glioblastoma multiforme
   Zhourui Ma et al, 2022, Apoptosis CrossRef
3. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death
   Peng-Hsu Chen et al, 2016, PLOS ONE CrossRef
4. Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway
   Hong-Chieh Tsai et al, 2021, Frontiers in Oncology CrossRef
5. TMZ regulates GBM stemness via MMP14‐DLL4‐Notch3 pathway
   Ilya V. Ulasov et al, 2020, International Journal of Cancer CrossRef
6. Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy
   Francesco Pasqualetti et al, 2018, Molecular Neurobiology CrossRef
7. MicroRNA Delivery by Graphene-Based Complexes into Glioblastoma Cells
   Marta Kutwin et al, 2021, Molecules CrossRef
8. Adiponectin receptor-mediated signaling ameliorates cerebral cell damage and regulates the neurogenesis of neural stem cells at high glucose concentrations: an in vivo and in vitro study
   J Song et al, 2015, Cell Death & Disease CrossRef
9. Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention
   Claudia Gasch et al, 2017, Molecular Cancer CrossRef
10. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway
    YANG XIA et al, 2015, Molecular Medicine Reports CrossRef
11. Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells
    Somruethai Sumkhemthong et al, 2021, Marine Drugs CrossRef
12. Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve
    Michael I Koukourakis et al, 2016, British Journal of Cancer CrossRef
13. Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest
    Peng Wang et al, 2016, Oncology Reports CrossRef
14. Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide
    Jilian R. Melamed et al, 2018, Oncotarget CrossRef
15. Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
    Alessia Lo Dico et al, 2018, Frontiers in Oncology CrossRef
16. Chemotherapy Resistance
    Adrienne C. Scheck, 2018, Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy CrossRef
17. Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer
    Arnab Sarkar et al, 2023, European Journal of Pharmacology CrossRef
18. Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma
    Claudia Del Vecchio et al, 2019, Cancers CrossRef
19. An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma
    Thomas Joyce et al, 2023, Current Oncology CrossRef
20. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis
    Chen Li et al, 2016, Journal of Molecular Neuroscience CrossRef
21. Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma
    Hao-Yi Li et al, 2024, Mitochondrion CrossRef
22. 4′‐Phenyl‐2,2′:6′,2′′‐terpyridine Derivatives Containing 1‐Substituted‐2,3‐Triazole Ring: Synthesis, Characterization and Anticancer Activity
    Dawid Zych et al, 2018, ChemistrySelect CrossRef